| Last Price (EGP) | 64.45 |
| Prev. Close | 64.770 |
| Day Range | 64.11 - 65.50 |
| 52WK range | |
| Turnover (M EGP) | 1.96 |
| Volume (M) | 0.03 |
| Number of Trades | 190 |
| Market Cap (M EGP) | 5,409.21 |
| Change in Market Cap (M EGP) | |
| VWAP (EGP) | 64.45 |
| EPS (TTM) | -- |
| EX-Dividend Date | |
| Dividend | |
| Dividend Yield (%) | |
| Beta | |
| 30D Avg Volume | |
| 30D Avg Turnover(M EGP) | |
| Outstanding Shares | |
| Free Float Shares | |
| Free Float % |
| Highest Market Cap | |
| Date of Highest Mkt. Cap | |
| Lowest Market Cap | |
| Date of Lowest Mkt. Cap |
Cairo - Mubasher: The consolidated net profits after tax of Glaxo SmithKline (GSK Egypt) reached EGP 30.21 million in the first nine months (9M) of...
Cairo - Egypt: GlaxoSmithKline (GSK Egypt) generated lower consolidated net profits after tax at EGP 65.05 million as of 30 June 2025, compared to EGP...
Cairo – Mubasher: GlaxoSmithKline (GSK Egypt) registered an annual growth in consolidated net profit after tax to EGP 105.82 million...
Cairo – Mubasher: GlaxoSmithKline (GSK Egypt) posted consolidated net profits amounting to EGP 92.55 million in the first half (H1)...
Cairo – Mubasher: GlaxoSmithKline (GSK Egypt) turned to a consolidated net loss of EGP 8.98 million in the first quarter (Q1) of 2024,...